Effectiveness and safety of ocrelizumab in relapsing-onset multiple sclerosis: A nationwide real-world study from Slovakia. Vitková M, Szilasiová J, Fedičová M, Kahancová E, Filippi P, Koleňáková K, Kiačiková M, Dziaková J, Bilá A, Laurincová S, et al. Mult Scler Relat Disord. 2026 Apr 13; 110:107202. PMID: 42013711. Abstract CommentRecommendBookmarkWatch